View as an RSS Feed
View Douglas Cress' Articles BY TICKER:
Cynosure: Growth Expected as Sales Go Global
on Jul. 23, 2008 • Comment!
- ICU Medical's Healthy Earnings
- Is Biolase On the Mend?
- Anika Therapeutics: Building On Previous Success
- ATS Medical Has Got Its Finger on the Pulse
- Will NeuroMetrix Inc. Win Back the Hearts of Investors?
- Compelling Impella: Abiomed May Double Its Revenues
- Google Health Unveiled: Open the Flood Gates
- Retractable Technologies: Robust Balance Sheet; Time to Make Some Moves
- Interview with Jim Datin, Executive VP & Managing Director of Safeguard Scientifics
- Merit Medical: Resilient and Poised for Continued Growth
- After Much Collaboration, Boston Scientific Buys CryoCor
- Stryker: Hefty Demand for Transport Solutions for Obese Patients
- Encision Inc. Strives to Enlarge Customer Base; Will Investors Get Burned?
- Interview with Craig Davenport, President & CEO of Endocare
- Interview with Ron Andrews, President & CEO of Clarient
- AngioDynamics: Has the Market Overreacted?
- Expect Big Things from Nuvasive
- STAAR Surgical Eyes Opportunity in Chinese Market
- Chembio & Bio-Rad Agreement: New Competition for Orasure?
- Google to Dominate Personal Health Record Space: Think Gmail for Medicine
- Allied Healthcare's Bleak Outlook
- Biolase CEO Draws the Company Out of an Abysmal Year
- ATS Medical Revises Guidance While It Seeks to Placate the FDA
- CombiMatrix and Clarient Partner to Market a More Sophisticated Cancer Test
- NovaDel Gets Approval for Insomnia Medicine - Longs Can Sleep Well
- Warburg Pincus: No Sign of Slow Down, Acquires Lifecore Biomedical
- Internet Site Revolution Health Takes on WebMD with User-Centric Focus
- Interview with Terrance Gregg, President & CEO of DexCom
- Caliper Life Sciences: Interview with Kevin Hrusovsky, CEO
- ATS Medical: Hopes FDA Approval Improves Profitability
- ATS Medical: Product Shows Early Promise